Argenica Therapeutics Ltd

NEW
ASX:AGN (Australia)   Ordinary Shares
A$ 0.15 (0%) Aug 4
At Loss
P/B:
5.75
Market Cap:
A$ 19.91M ($ 14.04M)
Enterprise V:
A$ 14.87M ($ 10.49M)
Volume:
7.18K
Avg Vol (2M):
419.32K
Trade In:
Volume:
7.18K
At Loss
Avg Vol (2M):
419.32K

Argenica Therapeutics Ltd (ASX:AGN) Dividend

Argenica Therapeutics Ltd (ASX:AGN) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -13.9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:AGN Dividend

Does Argenica Therapeutics Ltd (ASX:AGN) pay a dividend?

Argenica Therapeutics Ltd (ASX:AGN) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Argenica Therapeutics Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Argenica Therapeutics Ltd has returned capital to shareholders via buybacks at a rate of -13.9% over the past 3 years.

What are dividend-paying alternatives to Argenica Therapeutics Ltd?

For dividend-paying alternatives in Argenica Therapeutics Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.